神经在线共30篇
Recent Progress in Advancing Gene Therapy for Parkinson Disease: Russell Lonser, MD-爱医学

Recent Progress in Advancing Gene Therapy for Parkinson Disease: Russell Lonser, MD

WATCH TIME: 4 minutes'I think what gene therapy provides us is a new opportunity to really target the specific problem of the disease at its core.'AB-1005 (AskBio), an investigatio...
eason的头像-爱医学eason8个月前
390
Crossover Study Highlights Pharmacokinetic Effects of DHE Powder STS101-爱医学

Crossover Study Highlights Pharmacokinetic Effects of DHE Powder STS101

A recently published, randomized, open-label, 5-period crossover study showed that treatment with STS101, an intranasal dihydroergotamine (DHE) powder, was safe in healthy particip...
eason的头像-爱医学eason8个月前
270
NeuroVoices: Kayla Scippa, on Recognizing Unmet Need in Chronic Demyelinating Polyneuropathy-爱医学

NeuroVoices: Kayla Scippa, on Recognizing Unmet Need in Chronic Demyelinating Polyneuropathy

Chronic demyelinating polyneuropathy (CIDP) is a neuromuscular disorder characterized by progressive weakness and impaired sensory function in the arms and legs. It is an autoimmun...
eason的头像-爱医学eason8个月前
380
Promising Nasal Administration Treatment for Non-Active Secondary Progressive MS: Tarun Singhal, MD, MBBS-爱医学

Promising Nasal Administration Treatment for Non-Active Secondary Progressive MS: Tarun Singhal, MD, MBBS

WATCH TIME: 5 minutes'This approach with the nasal administration of the drug, we believe, actually leads to a modulation of the immune system in such a way that it makes it more r...
eason的头像-爱医学eason8个月前
230
Patient Death Reported in Phase 2 DAYLIGHT Study of Pfizer’s Gene Therapy for Duchenne-爱医学

Patient Death Reported in Phase 2 DAYLIGHT Study of Pfizer’s Gene Therapy for Duchenne

A patient in the phase 2 DALIGHT trial (NCT05429372) assessing Pfizer’s investigational gene therapy fordadistrogene movaparvovec (PF-06939926) in boys with Duchenne muscular dyst...
eason的头像-爱医学eason8个月前
230
ALS Candidate PrimeC Shows Greater Treatment Effect in High-Risk ALS-爱医学

ALS Candidate PrimeC Shows Greater Treatment Effect in High-Risk ALS

Jeremy M. Shefner, MD, PhDNewly announced analyses from the phase 2b PARADIGM trial (NCT05357950) showed that treatment with PrimeC (NeuroSense), an investigational agent made up o...
eason的头像-爱医学eason8个月前
280
Navigating Challenges and Opportunities With AI Adoption in Neurological Practice: Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN-爱医学

Navigating Challenges and Opportunities With AI Adoption in Neurological Practice: Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN

WATCH TIME: 5 minutes'What I really wanted to highlight is that we should be thinking about equity, and access. Many solutions might have the ability to increase clinician efficien...
eason的头像-爱医学eason8个月前
380
Understanding the Root of REM Behavior Disorder and Other Parasomnias-爱医学

Understanding the Root of REM Behavior Disorder and Other Parasomnias

Parasomnias are sleep disorders that involve abnormal behaviors, emotional experiences, perceptions, and dream activity, occurring during specific sleep stages or sleep-wake transi...
eason的头像-爱医学eason8个月前
290
Negative Myoclonus Associated With Severe Motor Implications in Progressive Myoclonus Ataxia-爱医学

Negative Myoclonus Associated With Severe Motor Implications in Progressive Myoclonus Ataxia

Marina A.J. Tijssen, MD, PhD(Credit: University of Groningen)In a newly published study in Movement Disorders, patients with progressive myoclonus ataxia (PMA) affected by negative...
eason的头像-爱医学eason8个月前
290
Cell-Based Therapies and Bembaneprocel-爱医学

Cell-Based Therapies and Bembaneprocel

At the 2024 American Academy of Neurology Annual Meeting, NeurologyLive® sat down with Parkinson disease (PD) expert Daniel Kremens, MD, JD, to discuss some of the top data being ...
eason的头像-爱医学eason8个月前
240